PM - Comprehensive Filing Intelligence
FY 2025•10-K•Filed Feb 6, 2026
5.0/10
Filing Health:CAUTION
Notable concerns that warrant closer review
Executive Summary
Net revenues grew 7.3% to $40.6 billion, driven by higher combustible tobacco pricing and increased smoke-free product volume, although cigarette volumes declined.. Significant one-time charges and gains heavily impacted diluted EPS in 2025, with a notable absence of a large 2024 impairment charge affecting year-over-year comparisons.. Contingent liabilities from tobacco/nicotine litigation could lead to significant financial impact, although the company believes it has valid defenses. Management has not concluded that a loss is probable or estimated a range of loss for these cases.. Europe segment revenue increased 9.05%
Top Concerns
- !Net revenues grew 7.3% to $40.6 billion, driven by higher combustible tobacco pricing and increased smoke-free product volume, although cigarette volumes declined.
- !Significant goodwill impairments occurred in prior periods ($680M in 2023) and a smaller one in the current period ($41M in 2025), indicating past overvaluation or changing business conditions.
- !Multiple large, non-recurring charges (e.g., Germany excise tax, South Korea indirect tax, Vectura loss) totaling nearly $1B raise concerns about the sustainability of reported earnings.
- !Contingent liabilities from tobacco/nicotine litigation could lead to significant financial impact, although the company believes it has valid defenses. Management has not concluded that a loss is probable or estimated a range of loss for these cases.
- !Geopolitical Instability and War in Ukraine (high)